Tularemia Pneumonia

Infectious Disease Clinics of North America

Volumn 24, Issue 1, 2010, Pages 43-55

  Thomas, Lora D ^a   Schaffner, William ^b  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bioterrorism; Francisella tularensis; Tularemia; Zoonosis

Indexed keywords

AMINOGLYCOSIDE; AZITHROMYCIN; BETA LACTAM; CHLORAMPHENICOL; CIPROFLOXACIN; DOXYCYCLINE; GENTAMICIN; IMMUNOGLOBULIN G; STREPTOMYCIN; TETRACYCLINE;

AGGLUTINATION TEST; ANTIBIOTIC THERAPY; ANTIBODY TITER; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM ISOLATE; BIOLOGICAL WARFARE; BLOOD DYSCRASIA; CLINICAL FEATURE; CONJUNCTIVITIS; DIAGNOSTIC PROCEDURE; DIARRHEA; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; EXPOSURE; FEVER; FOOD CONTAMINATION; FOOD INTAKE; FRANCISELLA TULARENSIS; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HEADACHE; HISTORY OF MEDICINE; HUMAN; INCIDENCE; LYMPHADENOPATHY; MENINGITIS; MORTALITY; MYALGIA; NONHUMAN; PATHOGENESIS; PHARYNGITIS; PNEUMONIA; POLYMERASE CHAIN REACTION; RASH; REVIEW; RISK FACTOR; SENSITIVITY AND SPECIFICITY; THORAX RADIOGRAPHY; TONSILLITIS; TREATMENT DURATION; TULAREMIA; WATER CONTAMINATION;

ANIMALS; ANTI-BACTERIAL AGENTS; BIOTERRORISM; FRANCISELLA TULARENSIS; HUMANS; PNEUMONIA, BACTERIAL; TULAREMIA; ZOONOSES;

EID: 76549106818     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2009.10.012     Document Type: Review

References (42)

1. Ellis J., Oyston P.C., Green M., et al. Tularemia. Clin Microbiol Rev 15 4 (2002) 631-646
2. Evans M.E., Gregory D.W., Schaffner W., et al. Tularemia: a 30-year experience with 88 cases. Medicine (Baltimore) 64 4 (1985) 251-269
3. Dienst F.T. Tularemia: a perusal of three hundred thirty-nine cases. J La State Med Soc 115 (1963) 114-127
4. Titball R.W., and Sjostedt A. Francisella tularensis: an overview. ASM News 69 11 (2003) 558-563
5. Gill V., and Cunha B.A. Tularemia pneumonia. Semin Respir Infect 12 1 (1997) 61-67
6. Scofield R.H., Lopez E.J., and McNabb S.J. Tularemia pneumonia in Oklahoma, 1982-1987. J Okla State Med Assoc 85 4 (1992) 165-170
7. Matyas B.T., Nieder H.S., and Telford S.R. Pneumonic tularemia on Martha's Vineyard: clinical epidemiologic, and ecological characteristics. Ann N Y Acad Sci 1105 (2007) 351-377
8. Rubin S.A. Radiographic spectrum of pleuropulmonary tularemia. AJR Am J Roentgenol 131 2 (1978) 277-281
9. Overholt E.L., Tigertt W.D., Kadull P.J., et al. An analysis of forty-two cases of laboratory-acquired tularemia. Am J Med 30 (1961) 785-806
10. Miller R.P., and Bates J.H. Pleuropulmonary tularemia. Am Rev Respir Dis 99 1 (1969) 31-41
11. Ohara S. Studies on Yato-Byo (Ohara's disease, tularemia in Japan), report I. Jpn J Exp Med 24 2 (1954) 69-79
12. McCoy G.W., and Chapin C.W. Further observations on a plague-like disease of rodents with a preliminary note on the causative agent Bacterium tularense. J Infect Dis 10 (1912) 61-72
13. Francis E. A summary of the present knowledge of tularemia. Medicine (Baltimore) 7 (1928) 411-432
14. Staples J.E., Kubota K.A., Chalcraft L.G., et al. Epidemiologic and molecular analysis of human tularemia, United States, 1964-2004. Emerg Infect Dis 12 7 (2006) 1113-1118
15. Kugeler K.J., Mead P.S., Janusz A.M., et al. Molecular epidemiology of Francisella tularensis in the United States. Clin Infect Dis 48 7 (2009) 863-870
16. Leelaporn A., Yongyod S., Limsrivanichakorn S., et al. Francisella novicida bacteremia, Thailand. Emerg Infect Dis 14 12 (2008) 1935-1937
17. Hollis D.G., Weaver R.E., Steigerwalt A.G., et al. Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J Clin Microbiol 27 7 (1989) 1601-1608
18. Penn R.L. Francisella tularensis (Tularemia). In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglas, and Bennett's principles and practice of infectious diseases (2005), Elsevier Churchill Livingstone, Philadelphia 2674-2686
19. Lamps L.W., Havens J.M., Sjostedt A., et al. Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America. Mod Pathol 17 5 (2004) 489-495
20. Barker J.R., and Klose K.E. Molecular and genetic basis of pathogenesis in Francisella tularensis. Ann N Y Acad Sci 1105 (2007) 138-159
21. Sjostedt A. Intracellular survival mechanism of Francisella tularensis, a stealth pathogen. Microbes Infect 8 2 (2006) 561-567
22. Tularemia. United States, 1990-2000. Centers for Disease Control and Prevention. MMWR Morb Mortal Wkly Rep 51 9 (2002) 181-184
23. Evans M.E., McGee Z.A., Hunter P.T., et al. Tularemia and the tomcat. JAMA 246 12 (1981) 1343
24. McCarthy V.P., and Murphy M.D. Lawnmower tularemia. Pediatr Infect Dis J 9 4 (1990) 298-300
25. Bellido-Casado J., Perez-Castrillon J.L., Bachiller-Luque P., et al. Report on five cases of tularaemic pneumonia in a tularaemia outbreak in Spain. Eur J Clin Microbiol Infect Dis 19 3 (2000) 218-220
26. Eliasson H., and Back E. Tularaemia in an emergent area of Sweden: an analysis of 234 cases in five years. Scand J Infect Dis 39 10 (2007) 880-889
27. Helvaci S., Gedikoglu S., Akalin H., et al. Tularemia in Bursa, Turkey: 205 cases in ten years. Eur J Epidemiol 16 3 (2000) 271-276
28. Ohara Y., Sato T., Fujita H., et al. Clinical manifestations of tularemia in Japan-analysis of 1355 cases observed between 1924 and 1987. Infection 19 1 (1991) 14-17
29. Teutsch S.M., Martone W.J., Brink E.W., et al. Pneumonic tularemia on Martha's Vineyard. N Engl J Med 301 15 (1979) 826-828
30. Feldman K.A., Enscore R.E., Lathrop S.L., et al. An outbreak of primary pneumonic tularemia on Martha's Vineyard. N Engl J Med 345 22 (2001) 1601-1606
31. Kaiser A.B., Rieves D., Price A.H., et al. Tularemia and rhabdomyolysis. JAMA 253 2 (1985) 241-243
32. Pettersson T., Nyberg P., Nordstrom D., et al. Similar pleural fluid findings in pleuropulmonary tularemia and tuberculous pleurisy. Chest 109 2 (1996) 572-575
33. Koskela P., and Salminen A. Humoral immunity against Francisella tularensis after natural infection. J Clin Microbiol 22 6 (1985) 973-979
34. Eliasson H., Sjostedt A., and Back E. Clinical use of diagnostic PCR for Francisella tularensis in patients with suspected ulceroglandular tularaemia. Scand J Infect Dis 37 (2005) 833-837
35. Penn R.L., and Kinasewitz G.T. Factors associated with a poor outcome in tularemia. Arch Intern Med 147 2 (1987) 265-268
36. Enderlin G., Morales L., Jacobs R.F., et al. Streptomycin and alternative agents for the treatment of tularemia: review of the literature. Clin Infect Dis 19 1 (1994) 42-47
37. Limaye A.P., and Hooper C.J. Treatment of tularemia with fluoroquinolones: two cases and review. Clin Infect Dis 29 4 (1999) 922-924
38. Meric M., Willke A., Finke E.J., et al. Evaluation of clinical, laboratory, and therapeutic features of 145 tularemia cases: the role of quinolones in oropharyngeal tularemia. APMIS 116 1 (2008) 66-73
39. Ikaheimo I., Syrjala H., Karhukorpi J., et al. In vitro antibiotic susceptibility of Francisella tularensis isolated from humans and animals. J Antimicrob Chemother 46 2 (2000) 287-290
40. Oyston P.C., Sjostedt A., and Titball R.W. Tularemia: bioterrorism defence renews interest in Francisella tularensis. Nat Rev Microbiol 2 12 (2004) 967-978
41. Dennis D.T., Inglesby T.V., Henderson D.A., et al. Tularemia as a biological weapon: medical and public health management. JAMA 285 21 (2001) 2763-2773
42. Burke D.S. Immunization against tularemia: analysis of the effectiveness of live Francisella tularensis vaccine in prevention of laboratory-acquired tularemia. J Infect Dis 135 1 (1977) 55-60